CAPRICOR THERAPEUTICS, INC.

CAPR · Nasdaq · SIC 2834: Pharmaceutical Preparations
363
SEC Filings

Business Summary

Capricor Therapeutics, Inc. is a Delaware-based biotechnology company focused on developing cell and exosome-based therapeutics for Duchenne muscular dystrophy (DMD) and other diseases with significant unmet medical need. Its lead product candidate, Deramiocel, is a cardiosphere-derived cell (CDC) therapy with a BLA under FDA review (PDUFA date: August 22, 2026). The company also advances its exosome platform (StealthX) for infectious diseases, monogenic diseases, and other indications through collaborations with NIH, DoD, Johns Hopkins, and others.

Next Earnings

Q2 FY2026 — expected 2026-08-15

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionCAPRdiscussed_in_filing Cybersecurity
topic_mentionCAPRdiscussed_in_filing Trusted Computing
topic_mentionCAPRdiscussed_in_filing Blockchain & Crypto
topic_mentionCAPRdiscussed_in_filing Regulation
topic_mentionCAPRdiscussed_in_filing Healthcare & Bio
topic_mentionCAPRdiscussed_in_filing Platform & Ecosystem
topic_mentionCAPRdiscussed_in_filing Sovereign & Government
topic_mentionCAPRdiscussed_in_filing Cybersecurity
topic_mentionCAPRdiscussed_in_filing Trusted Computing
topic_mentionCAPRdiscussed_in_filing Blockchain & Crypto
topic_mentionCAPRdiscussed_in_filing Regulation
topic_mentionCAPRdiscussed_in_filing Healthcare & Bio
topic_mentionCAPRdiscussed_in_filing Platform & Ecosystem
topic_mentionCAPRdiscussed_in_filing Sovereign & Government
topic_mentionCAPRdiscussed_in_filing Cybersecurity
topic_mentionCAPRdiscussed_in_filing Trusted Computing
topic_mentionCAPRdiscussed_in_filing Blockchain & Crypto
topic_mentionCAPRdiscussed_in_filing Regulation
topic_mentionCAPRdiscussed_in_filing Healthcare & Bio
topic_mentionCAPRdiscussed_in_filing Platform & Ecosystem

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-172025-12-310001104659-26-029580EDGAR90K words
2025-03-262024-12-310001558370-25-003707EDGAR—
2024-03-112023-12-310001558370-24-002861EDGAR—
2023-03-172022-12-310001558370-23-004124EDGAR—
2022-03-112021-12-310001558370-22-003341EDGAR—
2021-03-152020-12-310001104659-21-036410EDGAR—
2020-03-272019-12-310001104659-20-039272EDGAR—
2019-03-292018-12-310001144204-19-016787EDGAR—
2018-03-222017-12-310001144204-18-016468EDGAR—
2017-03-162016-12-310001144204-17-014866EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-102025-09-300001104659-25-109298EDGAR32K words
2025-08-112025-06-300001558370-25-011084EDGAR—
2025-05-142025-03-310001558370-25-007770EDGAR—
2024-11-142024-09-300001558370-24-015730EDGAR—
2024-08-082024-06-300001558370-24-011638EDGAR—
2024-05-142024-03-310001558370-24-008072EDGAR—
2023-11-142023-09-300001558370-23-019065EDGAR—
2023-08-082023-06-300001558370-23-013763EDGAR—
2023-05-122023-03-310001558370-23-009521EDGAR—
2022-11-102022-09-300001558370-22-017470EDGAR—
2022-08-122022-06-300001558370-22-013383EDGAR—
2022-05-112022-03-310001558370-22-008347EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-120001104659-26-027037EDGAR3K words
2026-03-100001104659-26-025657EDGAR—
2025-12-050001104659-25-118934EDGAR—
2025-12-030001104659-25-117981EDGAR—
2025-12-030001104659-25-117947EDGAR—
2025-11-100001104659-25-109119EDGAR—
2025-08-110001558370-25-011047EDGAR—
2025-07-110001558370-25-009186EDGAR—
2025-05-270001558370-25-008145EDGAR—
2025-05-130001558370-25-007574EDGAR—

363 total filings indexed. 331 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Tags

rare-genetic-disorders-(duchenne-muscular-dystrophy) cell-therapy exosome-based-therapeutics-and-vaccines infectious-diseases monogenic-diseases

Company Identity

CIK0001133869
TickerCAPR
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: e4e61b16426c5487258a1f8716170ffd96936ca8196010c61daeafceb7c19f2e
parent: 97b3c444f5e5bfcaa47d08cf9a0131b7df89dcc5bd6fcdb568b76942d79f0297
content hash: e84022e42002af73f26d1e1c0bf7cc1ab09127c013b05ad05be9ee639b4eec39
signed: 2026-04-13T04:44:11.706Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf